We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$812B
AUM Growth
-$55.8B
Cap. Flow
-$18.8B
Cap. Flow %
-2.31%
Top 10 Hldgs %
32.22%
Holding
3,109
New
91
Increased
2,002
Reduced
738
Closed
70

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.81B
2
XYZ
Block Inc
XYZ
+$1.46B
3
ACN icon
Accenture
ACN
+$1.23B
4
GILD icon
Gilead Sciences
GILD
+$1.15B
5
VLO icon
Valero Energy
VLO
+$1.05B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.61B
2
META icon
Meta Platforms (Facebook)
META
+$2.06B
3
TSLA icon
Tesla
TSLA
+$1.81B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.72B
5
AMZN icon
Amazon
AMZN
+$1.59B

Sector Composition

Rank Sector Weight
1 Technology 30.44%
2 Healthcare 13.92%
3 Financials 12.3%
4 Consumer Discretionary 10.98%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OUST icon
2651
Ouster
OUST
$3.25B
$188K ﹤0.01%
20,879
+2,234
+12% +$22K
RGNX icon
2652
Regenxbio
RGNX
$704M
$188K ﹤0.01%
26,200
+2,290
+10% +$17K
WOOF icon
2653
Petco
WOOF
$817M
$188K ﹤0.01%
61,542
+4,373
+8% +$13.7K
ARAY icon
2654
Accuray
ARAY
$32.9M
$187K ﹤0.01%
104,212
+7,066
+7% +$14.8K
DNUT icon
2655
Krispy Kreme
DNUT
$569M
$187K ﹤0.01%
37,814
+4,727
+14% +$36.1K
MAX icon
2656
MediaAlpha
MAX
$813M
$187K ﹤0.01%
20,236
VIPS icon
2657
Vipshop
VIPS
$6.8B
$186K ﹤0.01%
11,800
KELYA icon
2658
Kelly Services Class A
KELYA
$566M
$185K ﹤0.01%
13,973
+1,590
+13% +$21.7K
EVLV icon
2659
Evolv Technologies
EVLV
$1.04B
$184K ﹤0.01%
58,859
+5,634
+11% +$19.8K
MRVI icon
2660
Maravai LifeSciences
MRVI
$861M
$184K ﹤0.01%
82,823
+11,995
+17% +$47.4K
KOPN icon
2661
Kopin
KOPN
$898M
$182K ﹤0.01%
194,300
-16,900
-8% -$24.9K
DFTX
2662
Definium Therapeutics
DFTX
$5.9B
$182K ﹤0.01%
30,945
-368
-1% -$2.64K
ESPR
2663
DELISTED
Esperion Therapeutics
ESPR
$181K ﹤0.01%
125,553
+1,657
+1% +$3.05K
MVST icon
2664
Microvast
MVST
$341M
$181K ﹤0.01%
154,200
QUBT icon
2665
Quantum Computing Inc
QUBT
$2.02B
$180K ﹤0.01%
+22,458
New +$198K
REI icon
2666
Ring Energy
REI
$349M
$180K ﹤0.01%
155,988
+2,832
+2% +$3.69K
CHPT icon
2667
ChargePoint
CHPT
$160M
$179K ﹤0.01%
14,793
+1,136
+8% +$18.9K
STRS
2668
DELISTED
STRATUS PPTYS INC
STRS
$179K ﹤0.01%
10,061
SWBI icon
2669
Smith & Wesson
SWBI
$643M
$178K ﹤0.01%
19,045
+1,735
+10% +$17.9K
OPTU
2670
Optimum Communications Inc
OPTU
$228M
$177K ﹤0.01%
66,400
ETWO
2671
DELISTED
E2open Parent Holdings
ETWO
$177K ﹤0.01%
88,002
+10,095
+13% +$25K
TMCI icon
2672
Treace Medical Concepts
TMCI
$293M
$177K ﹤0.01%
20,999
+1,943
+10% +$17.5K
ASC icon
2673
Ardmore Shipping
ASC
$707M
$176K ﹤0.01%
17,961
+2,107
+13% +$23K
UWMC icon
2674
UWM Holdings
UWMC
$2.61B
$176K ﹤0.01%
32,152
+2,675
+9% +$16.2K
CDZI icon
2675
Cadiz
CDZI
$295M
$175K ﹤0.01%
59,636

Similar funds

T. Rowe Price Associates's Q1 2025 Portfolio in Review

As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
  • T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
  • T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
  • T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
  • T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
  • T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.